PANITUMUMAB

PANITUMUMAB was reported 16107 times

PANITUMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRICHOMEGALY 35 0.7955
1 DEPILATION 16 0.4571
2 COLORECTAL CANCER METASTATIC 861 0.3630
3 COLORECTAL CANCER RECURRENT 37 0.2868
4 RECTOSIGMOID CANCER METASTATIC 9 0.2432
5 DIAPHRAGMATIC OPERATION 7 0.2121
6 ASTRINGENT THERAPY 6 0.1935
7 DERMATITIS ACNEIFORM 1069 0.1755
8 COLOSTOMY BAG USER 6 0.1714
9 SKIN TOXICITY 935 0.1653
10 XERODERMA 43 0.1610
11 LIVER ABLATION 12 0.1579
12 INTESTINAL TRANSIT TIME ABNORMAL 8 0.1455
13 ECZEMA IMPETIGINOUS 6 0.1395
14 PARONYCHIA 591 0.1343
15 RECTAL CANCER METASTATIC 44 0.1264
16 HEPATECTOMY 34 0.1086
17 TRANSIENT APHASIA 13 0.0992
18 MUCOCUTANEOUS TOXICITY 10 0.0952
19 RECTAL CANCER RECURRENT 7 0.0824
20 CLONAL HAEMATOPOIESIS 6 0.0779
21 MUCOCUTANEOUS RASH 12 0.0779
22 COLORECTAL ADENOCARCINOMA 17 0.0759
23 NAIL BED INFLAMMATION 24 0.0752
24 ADENOCARCINOMA METASTATIC 15 0.0728
25 LIVER OPERATION 21 0.0682
26 EYELASH CHANGES 12 0.0678
27 ACNE PUSTULAR 55 0.0671
28 COLON CANCER RECURRENT 18 0.0652
29 XEROSIS 77 0.0622
30 HYPOMAGNESAEMIA 848 0.0608
31 ADENOCARCINOMA OF COLON 113 0.0603
32 MUCOSAL TOXICITY 16 0.0590
33 EYELASH THICKENING 7 0.0583
34 COLON CANCER METASTATIC 93 0.0577
35 URINOMA 9 0.0570
36 ADJUSTED CALCIUM DECREASED 6 0.0566
37 ECTROPION 19 0.0564
38 GROWTH OF EYELASHES 43 0.0543
39 RASH FOLLICULAR 8 0.0519
40 CARCINOEMBRYONIC ANTIGEN INCREASED 100 0.0516
41 METASTASES TO OVARY 16 0.0502
42 RASH PUSTULAR 337 0.0462
43 RECTAL ADENOCARCINOMA 27 0.0446
44 STOMA SITE ULCER 7 0.0395
45 CARBOHYDRATE ANTIGEN 19-9 INCREASED 20 0.0378
46 CATHETER SITE THROMBOSIS 10 0.0365
47 DERMATITIS INFECTED 18 0.0362
48 THERAPY PARTIAL RESPONDER 480 0.0307
49 TUMOUR PERFORATION 9 0.0283
50 PYOGENIC GRANULOMA 13 0.0279
51 GENE MUTATION 54 0.0273
52 METASTASES TO PELVIS 17 0.0269
53 METASTASES TO PERITONEUM 67 0.0265
54 COLOSTOMY CLOSURE 9 0.0263
55 METASTASES TO LIVER 454 0.0258
56 PROCTECTOMY 7 0.0255
57 INTESTINAL METASTASIS 9 0.0248
58 HYPERTRICHOSIS 44 0.0237
59 PUSTULE 56 0.0236
60 BLOOD MAGNESIUM ABNORMAL 13 0.0235
61 NAIL TOXICITY 7 0.0233
62 XEROPHTHALMIA 13 0.0221
63 PULMONARY ARTERY THROMBOSIS 17 0.0221
64 POLYNEUROPATHY 264 0.0220
65 PERIPHERAL SENSORY NEUROPATHY 127 0.0217
66 INTRAVASCULAR HAEMOLYSIS 12 0.0214
67 NEPHROSTOMY 7 0.0212
68 PIK3CA-ACTIVATED MUTATION 7 0.0211
69 SKIN REACTION 295 0.0209
70 ILEOSTOMY CLOSURE 7 0.0209
71 OCULAR TOXICITY 23 0.0208
72 CANCER SURGERY 19 0.0198
73 ILEAL PERFORATION 13 0.0196
74 SKIN WOUND 33 0.0194
75 CHOLINERGIC SYNDROME 12 0.0188
76 ANGULAR CHEILITIS 13 0.0188
77 BLOOD MAGNESIUM DECREASED 162 0.0188
78 COLON CANCER 278 0.0186
79 NEUROSARCOIDOSIS 7 0.0186
80 PSEUDOCIRRHOSIS 6 0.0181
81 METASTASES TO LUNG 208 0.0180
82 CONJUNCTIVITIS BACTERIAL 6 0.0175
83 NAIL INJURY 10 0.0175
84 PERIORAL DERMATITIS 11 0.0173
85 COLON OPERATION 20 0.0167
86 RECTAL PERFORATION 9 0.0167
87 CUTANEOUS SYMPTOM 11 0.0161
88 SKIN FISSURES 314 0.0161
89 HYDROURETER 6 0.0158
90 CONJUNCTIVAL DISORDER 6 0.0157
91 PERITONEAL DISORDER 10 0.0154
92 THROMBOCYTOPENIC PURPURA 21 0.0154
93 RECTAL CANCER 47 0.0153
94 COLOSTOMY 29 0.0148
95 METASTASES TO THE MEDIASTINUM 6 0.0146
96 SUPERINFECTION BACTERIAL 11 0.0139
97 TRACHEAL STENOSIS 7 0.0138
98 PHIMOSIS 10 0.0136
99 ONYCHOLYSIS 21 0.0134
100 HEPATIC LESION 57 0.0132
101 ANASTOMOTIC LEAK 9 0.0130
102 GASTROINTESTINAL TOXICITY 62 0.0129
103 HEPATIC CANCER METASTATIC 11 0.0129
104 MUCOSAL INFLAMMATION 335 0.0128
105 METASTASES TO LYMPH NODES 86 0.0127
106 FOLLICULITIS 132 0.0126
107 KLEBSIELLA TEST POSITIVE 8 0.0123
108 METASTASES TO ABDOMINAL CAVITY 6 0.0122
109 PELVIC ABSCESS 14 0.0122
110 BALANOPOSTHITIS 10 0.0122
111 ADENOCARCINOMA 27 0.0120
112 SUBILEUS 25 0.0120
113 POSTOPERATIVE ABSCESS 8 0.0119
114 BONE MARROW TOXICITY 14 0.0118
115 NEUROTOXICITY 194 0.0111
116 HYPERAMYLASAEMIA 6 0.0110
117 DILATED CARDIOMYOPATHY 11 0.0109
118 KERATITIS 33 0.0108
119 VENA CAVA THROMBOSIS 18 0.0108
120 NASAL CRUSTING 7 0.0108
121 SHORT-BOWEL SYNDROME 7 0.0108
122 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 247 0.0106
123 SKIN LESION 290 0.0106
124 COLONIC FISTULA 6 0.0105
125 MECHANICAL ILEUS 6 0.0105
126 MALIGNANT ASCITES 8 0.0104
127 CONJUNCTIVITIS 191 0.0103
128 SKIN DISORDER 338 0.0101
129 CAMPYLOBACTER GASTROENTERITIS 6 0.0101
130 STOMATITIS 612 0.0101
131 MUCOSAL DISORDER 10 0.0101
132 LIVEDO RETICULARIS 21 0.0100
133 HEPATIC NEOPLASM 32 0.0098
134 STAPHYLOCOCCAL SKIN INFECTION 12 0.0098
135 STOMA SITE HAEMORRHAGE 15 0.0097
136 SUBCLAVIAN VEIN THROMBOSIS 11 0.0097
137 HYPOCALCAEMIA 181 0.0096
138 TUMOUR NECROSIS 10 0.0095
139 HAEMATOTOXICITY 89 0.0094
140 BLEPHARITIS 37 0.0092
141 DEVICE RELATED THROMBOSIS 9 0.0091
142 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
143 ONYCHALGIA 9 0.0090
144 DECREASED IMMUNE RESPONSIVENESS 88 0.0090
145 RECTAL TENESMUS 11 0.0088
146 PERIPHERAL MOTOR NEUROPATHY 12 0.0086
147 IGA NEPHROPATHY 14 0.0084
148 TUMOUR MARKER INCREASED 40 0.0083
149 IMPETIGO 12 0.0080
150 ENTEROVESICAL FISTULA 6 0.0079
151 INTERSTITIAL LUNG DISEASE 383 0.0079
152 NEUROPATHY PERIPHERAL 749 0.0079
153 DEMYELINATING POLYNEUROPATHY 8 0.0078
154 RADIATION SKIN INJURY 9 0.0078
155 ILEUS 96 0.0077
156 TONIC CLONIC MOVEMENTS 10 0.0077
157 LYMPHANGIOSIS CARCINOMATOSA 8 0.0077
158 CHOLANGITIS 47 0.0076
159 SKIN INJURY 25 0.0075
160 HYPERAMMONAEMIC ENCEPHALOPATHY 13 0.0075
161 LYMPHANGITIS 6 0.0075
162 WRONG SCHEDULE 7 0.0073
163 DERMATITIS 153 0.0073
164 COLON NEOPLASM 7 0.0073
165 GASTROENTERITIS SALMONELLA 6 0.0072
166 NEUTROPENIA 963 0.0071
167 DEVICE RELATED SEPSIS 14 0.0069
168 ENTEROCOLITIS 40 0.0069
169 NASAL ULCER 11 0.0069
170 STOMA COMPLICATION 7 0.0069
171 LYMPHADENOPATHY MEDIASTINAL 13 0.0068
172 HIRSUTISM 9 0.0068
173 LABILE BLOOD PRESSURE 8 0.0067
174 APHTHOUS ULCER 52 0.0067
175 BILE DUCT STENOSIS 8 0.0067
176 EMBOLISM ARTERIAL 8 0.0067
177 NAIL DISORDER 58 0.0066
178 MOUTH INJURY 10 0.0066
179 SCAB 74 0.0065
180 PORTAL HYPERTENSION 20 0.0065
181 OESOPHAGEAL VARICES HAEMORRHAGE 14 0.0064
182 DISCOURAGEMENT 15 0.0064
183 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
184 PROCTALGIA 41 0.0064
185 DISEASE PROGRESSION 749 0.0063
186 NAIL INFECTION 9 0.0063
187 VENOOCCLUSIVE LIVER DISEASE 31 0.0063
188 ORAL DISORDER 46 0.0063
189 PULMONARY SARCOIDOSIS 7 0.0062
190 HEPATIC MASS 12 0.0062
191 JUGULAR VEIN THROMBOSIS 11 0.0062
192 PIGMENTATION DISORDER 38 0.0061
193 PNEUMOMEDIASTINUM 11 0.0061
194 PALMAR ERYTHEMA 7 0.0061
195 EXFOLIATIVE RASH 16 0.0061
196 SEBORRHOEIC DERMATITIS 10 0.0060
197 ACUTE PRERENAL FAILURE 7 0.0060
198 METASTASIS 43 0.0060
199 GASTROINTESTINAL PERFORATION 25 0.0060
200 HYPERAMMONAEMIA 30 0.0060
201 RASH MACULO-PAPULAR 133 0.0060
202 VENOUS THROMBOSIS 23 0.0059
203 SKIN HAEMORRHAGE 86 0.0058
204 BILE DUCT OBSTRUCTION 11 0.0058
205 ACNE 437 0.0058
206 GASTROINTESTINAL STOMA COMPLICATION 9 0.0057
207 NECROTISING FASCIITIS 20 0.0057
208 HYPOALBUMINAEMIA 44 0.0057
209 PULMONARY TOXICITY 40 0.0057
210 DEVICE RELATED INFECTION 87 0.0056
211 NEUTROPHIL COUNT DECREASED 230 0.0056
212 GLOSSITIS 20 0.0056
213 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 7 0.0056
214 VARICES OESOPHAGEAL 17 0.0056
215 HYDRONEPHROSIS 42 0.0056
216 PORTAL VEIN THROMBOSIS 18 0.0056
217 SENSITIVE SKIN 41 0.0056
218 PAPULE 39 0.0055
219 DRY SKIN 717 0.0054
220 ACQUIRED GENE MUTATION 7 0.0053
221 TUMOUR PAIN 7 0.0053
222 THROMBOCYTOPENIA 591 0.0053
223 COLORECTAL CANCER 252 0.0053
224 PNEUMATOSIS INTESTINALIS 15 0.0053
225 ORAL MUCOSAL ERUPTION 8 0.0052
226 LARYNGOSPASM 14 0.0052
227 HYPOKALAEMIA 240 0.0052
228 LARGE INTESTINE PERFORATION 36 0.0052
229 INTERCEPTED PRODUCT ADMINISTRATION ERROR 39 0.0051
230 CANCER PAIN 13 0.0051
231 GASTROINTESTINAL OBSTRUCTION 12 0.0050
232 FEBRILE BONE MARROW APLASIA 21 0.0049
233 TETANY 9 0.0049
234 ORAL MUCOSA EROSION 6 0.0049
235 VENOUS THROMBOSIS LIMB 10 0.0048
236 FEBRILE NEUTROPENIA 320 0.0048
237 CHEILITIS 26 0.0048
238 SUBCUTANEOUS ABSCESS 23 0.0048
239 PERIPHERAL SENSORIMOTOR NEUROPATHY 6 0.0048
240 ABDOMINAL ABSCESS 21 0.0047
241 PERFORMANCE STATUS DECREASED 22 0.0047
242 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 159 0.0047
243 CHOLANGIOCARCINOMA 7 0.0047
244 ILEOSTOMY 12 0.0047
245 ENDOCRINE DISORDER 6 0.0047
246 SUPERINFECTION 7 0.0047
247 SKIN EROSION 15 0.0047
248 INGROWING NAIL 11 0.0047
249 HAIR GROWTH ABNORMAL 32 0.0046
250 ANAPHYLACTOID REACTION 19 0.0046
251 PANNICULITIS 11 0.0045
252 RASH 1979 0.0045
253 LEUKOPENIA 227 0.0045
254 AZOTAEMIA 18 0.0045
255 METASTASES TO CENTRAL NERVOUS SYSTEM 58 0.0045
256 NEUTROPENIC SEPSIS 32 0.0045
257 LARGE INTESTINAL OBSTRUCTION 10 0.0045
258 INTESTINAL OPERATION 7 0.0044
259 EMBOLISM 36 0.0043
260 CATHETER PLACEMENT 8 0.0043
261 ELECTROLYTE IMBALANCE 49 0.0042
262 GENITAL RASH 6 0.0042
263 ASCITES 122 0.0041
264 CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0041
265 FEMALE GENITAL TRACT FISTULA 7 0.0041
266 AMYLASE INCREASED 15 0.0041
267 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
268 HYPOPHOSPHATAEMIA 30 0.0041
269 UNDERWEIGHT 8 0.0041
270 SKIN WRINKLING 11 0.0040
271 ANORECTAL DISORDER 8 0.0040
272 CENTRAL VENOUS CATHETERISATION 12 0.0040
273 HYPERBILIRUBINAEMIA 41 0.0040
274 PAIN OF SKIN 106 0.0039
275 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 7 0.0039
276 PROCTITIS 11 0.0039
277 ONYCHOCLASIS 27 0.0039
278 PALLIATIVE CARE 6 0.0039
279 ENTERITIS 25 0.0039
280 DUODENAL ULCER HAEMORRHAGE 11 0.0038
281 BLOOD PHOSPHORUS DECREASED 14 0.0038
282 REFUSAL OF TREATMENT BY PATIENT 25 0.0038
283 BLOOD CALCIUM DECREASED 43 0.0038
284 INTESTINAL OBSTRUCTION 144 0.0038
285 ONYCHOMADESIS 16 0.0038
286 OSTEOSCLEROSIS 6 0.0038
287 HEPATIC NECROSIS 14 0.0037
288 TYPE I HYPERSENSITIVITY 13 0.0037
289 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
290 SKIN INFECTION 41 0.0037
291 ULCERATIVE KERATITIS 10 0.0036
292 NEPHROTIC SYNDROME 25 0.0036
293 SKIN TIGHTNESS 17 0.0036
294 INTESTINAL PERFORATION 40 0.0036
295 MULTIPLE-DRUG RESISTANCE 11 0.0035
296 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 7 0.0035
297 IMMUNE THROMBOCYTOPENIA 16 0.0035
298 EYELID DISORDER 8 0.0035
299 THROMBOTIC THROMBOCYTOPENIC PURPURA 12 0.0034
300 PULMONARY INFARCTION 8 0.0034
301 PROTEINURIA 64 0.0034
302 ERYTHEMA MULTIFORME 31 0.0033
303 HEPATIC FAILURE 100 0.0033
304 NEOPLASM PROGRESSION 115 0.0033
305 PURPURA 29 0.0033
306 BONE MARROW FAILURE 66 0.0032
307 CHAPPED LIPS 14 0.0032
308 ANAL HAEMORRHAGE 9 0.0032
309 CATHETER SITE INFECTION 12 0.0032
310 SMALL INTESTINAL OBSTRUCTION 39 0.0032
311 DANDRUFF 7 0.0032
312 HYPOPROTEINAEMIA 6 0.0032
313 ANAL ABSCESS 17 0.0032
314 JAUNDICE CHOLESTATIC 11 0.0031
315 NAIL DISCOLOURATION 12 0.0030
316 HYPERAEMIA 6 0.0030
317 PNEUMONIA STAPHYLOCOCCAL 6 0.0030
318 PHOTOSENSITIVITY REACTION 50 0.0030
319 MUCOSAL DRYNESS 6 0.0030
320 TOXIC SKIN ERUPTION 30 0.0030
321 CORONARY ARTERY THROMBOSIS 6 0.0030
322 SKIN ATROPHY 17 0.0030
323 HEPATIC CYST 10 0.0029
324 THROAT CLEARING 11 0.0029
325 FIBROSIS 9 0.0029
326 CACHEXIA 15 0.0029
327 SKIN NECROSIS 15 0.0029
328 PYELONEPHRITIS 25 0.0029
329 DERMATITIS ALLERGIC 36 0.0029
330 THROMBOPHLEBITIS 10 0.0028
331 RENAL TUBULAR DISORDER 8 0.0028
332 HEPATOTOXICITY 63 0.0028
333 CATHETER SITE ERYTHEMA 6 0.0028
334 TUMOUR HAEMORRHAGE 8 0.0028
335 PULMONARY EMBOLISM 266 0.0028
336 ANAEMIA 528 0.0028
337 ABDOMINAL INFECTION 7 0.0027
338 HYPERTRANSAMINASAEMIA 19 0.0027
339 MOUTH ULCERATION 57 0.0027
340 DUODENAL ULCER 19 0.0027
341 ILEUS PARALYTIC 12 0.0027
342 METASTASES TO BONE 44 0.0027
343 SKIN HYPERPIGMENTATION 23 0.0027
344 TONGUE ULCERATION 9 0.0027
345 NEOPLASM RECURRENCE 9 0.0027
346 EMBOLISM VENOUS 8 0.0026
347 GRANULOCYTOPENIA 15 0.0026
348 SKIN ULCER 68 0.0026
349 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
350 ANAL FISTULA 14 0.0026
351 APHTHOUS STOMATITIS 6 0.0026
352 PNEUMONITIS 70 0.0026
353 HICCUPS 21 0.0026
354 DIARRHOEA 1651 0.0026
355 DRUG RESISTANCE 65 0.0025
356 BLOOD ALBUMIN DECREASED 20 0.0025
357 JAUNDICE 67 0.0025
358 NEUTROPHIL COUNT ABNORMAL 7 0.0025
359 DECREASED APPETITE 573 0.0025
360 LIVER ABSCESS 8 0.0025
361 FACIAL PAIN 22 0.0025
362 PANCREATIC CARCINOMA METASTATIC 7 0.0025
363 RASH PAPULAR 55 0.0025
364 DEHYDRATION 326 0.0024
365 SKIN EXFOLIATION 205 0.0024
366 VASCULAR DEVICE INFECTION 11 0.0024
367 GASTROINTESTINAL NECROSIS 7 0.0024
368 ERYTHEMA 492 0.0024
369 EYELID IRRITATION 6 0.0024
370 ERYSIPELAS 12 0.0024
371 COLITIS ISCHAEMIC 16 0.0024
372 INFUSION RELATED REACTION 157 0.0024
373 HYPERTHERMIA 18 0.0024
374 PULMONARY MASS 35 0.0023
375 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
376 MALIGNANT NEOPLASM PROGRESSION 240 0.0023
377 HEPATIC FIBROSIS 8 0.0023
378 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
379 EYE DISCHARGE 24 0.0023
380 SPINAL COMPRESSION FRACTURE 19 0.0023
381 HYPOVOLAEMIC SHOCK 11 0.0023
382 PRODUCT STORAGE ERROR 200 0.0023
383 RADICULOPATHY 6 0.0023
384 RASH VESICULAR 11 0.0023
385 GENERAL PHYSICAL HEALTH DETERIORATION 261 0.0023
386 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
387 CONJUNCTIVAL HYPERAEMIA 8 0.0022
388 ARTERIOSPASM CORONARY 9 0.0022
389 SKIN BURNING SENSATION 159 0.0022
390 ABDOMINAL ADHESIONS 7 0.0022
391 ABDOMINAL HERNIA 10 0.0022
392 POST PROCEDURAL COMPLICATION 42 0.0022
393 HYPERKERATOSIS 12 0.0022
394 WOUND HAEMORRHAGE 8 0.0022
395 TUMOUR LYSIS SYNDROME 19 0.0022
396 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
397 BLOOD BILIRUBIN INCREASED 58 0.0021
398 COLITIS 81 0.0021
399 PROTEIN TOTAL DECREASED 8 0.0021
400 ABSCESS LIMB 9 0.0021
401 GENERALISED ERYTHEMA 12 0.0021
402 LUNG NEOPLASM 9 0.0021
403 CARDIAC FAILURE ACUTE 14 0.0021
404 WOUND INFECTION 23 0.0021
405 METASTATIC NEOPLASM 9 0.0021
406 LUNG CANCER METASTATIC 6 0.0021
407 MALNUTRITION 23 0.0021
408 COMPRESSION FRACTURE 11 0.0021
409 ACUTE CORONARY SYNDROME 17 0.0021
410 PROCEDURAL HAEMORRHAGE 8 0.0020
411 HEPATOMEGALY 20 0.0020
412 STAPHYLOCOCCAL SEPSIS 10 0.0020
413 FURUNCLE 16 0.0020
414 DEEP VEIN THROMBOSIS 131 0.0020
415 URINARY TRACT DISORDER 9 0.0020
416 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 19 0.0020
417 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
418 LIP DRY 18 0.0020
419 DYSCHEZIA 6 0.0020
420 PYODERMA GANGRENOSUM 7 0.0019
421 DERMATITIS BULLOUS 14 0.0019
422 AORTIC DISSECTION 8 0.0019
423 FAILURE TO THRIVE 10 0.0019
424 METABOLIC DISORDER 11 0.0019
425 BRONCHOSPASM 27 0.0019
426 BILE DUCT STONE 6 0.0019
427 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
428 ANORECTAL DISCOMFORT 10 0.0019
429 GASTROINTESTINAL MOTILITY DISORDER 10 0.0019
430 OCCUPATIONAL EXPOSURE TO PRODUCT 12 0.0019
431 ANAPHYLACTIC SHOCK 48 0.0019
432 PLEURISY 11 0.0019
433 HERPES SIMPLEX 12 0.0018
434 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
435 OESOPHAGITIS 20 0.0018
436 FEEDING DISORDER 37 0.0018
437 OESOPHAGEAL ULCER 7 0.0018
438 DRUG ERUPTION 32 0.0018
439 RASH ERYTHEMATOUS 86 0.0018
440 HEPATIC FUNCTION ABNORMAL 67 0.0018
441 CARDIOTOXICITY 16 0.0018
442 WOUND SECRETION 7 0.0018
443 HAEMOLYTIC ANAEMIA 16 0.0018
444 PAPILLOEDEMA 8 0.0018
445 SUSPECTED OFF LABEL USE 8 0.0018
446 PLATELET COUNT DECREASED 188 0.0018
447 LIVER DISORDER 78 0.0018
448 MYOCARDIAL ISCHAEMIA 20 0.0018
449 ABSCESS 28 0.0018
450 TEMPERATURE INTOLERANCE 18 0.0017
451 RASH GENERALISED 45 0.0017
452 HERPES VIRUS INFECTION 10 0.0017
453 LOCALISED OEDEMA 8 0.0017
454 FACE OEDEMA 29 0.0017
455 HEPATIC ENCEPHALOPATHY 16 0.0017
456 STEVENS-JOHNSON SYNDROME 38 0.0017
457 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
458 EPISTAXIS 126 0.0017
459 CEREBRAL INFARCTION 41 0.0017
460 ODYNOPHAGIA 10 0.0017
461 HEPATIC STEATOSIS 31 0.0017
462 BLOOD POTASSIUM DECREASED 50 0.0017
463 ADVERSE REACTION 22 0.0017
464 SKIN LACERATION 18 0.0017
465 PLATELET COUNT ABNORMAL 10 0.0017
466 TONGUE DISCOMFORT 7 0.0016
467 ASTHENIA 620 0.0016
468 HEPATIC CYTOLYSIS 21 0.0016
469 PURULENT DISCHARGE 7 0.0016
470 INTESTINAL ISCHAEMIA 9 0.0016
471 NECROSIS 9 0.0016
472 LYMPHADENOPATHY 57 0.0016
473 INFARCTION 11 0.0016
474 SUDDEN DEATH 17 0.0016
475 HYPERNATRAEMIA 8 0.0016
476 TONGUE DISCOLOURATION 7 0.0016
477 BEDRIDDEN 21 0.0016
478 MELANOCYTIC NAEVUS 7 0.0016
479 NASAL DRYNESS 10 0.0016
480 COLECTOMY 9 0.0016
481 HYPERAESTHESIA 13 0.0016
482 KLEBSIELLA INFECTION 8 0.0016
483 PHLEBITIS 8 0.0016
484 FAECES HARD 6 0.0015
485 CARDIOPULMONARY FAILURE 6 0.0015
486 PETECHIAE 16 0.0015
487 PYREXIA 523 0.0015
488 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
489 GASTROENTERITIS 22 0.0015
490 HYPOXIA 53 0.0015
491 NEPHROPATHY 14 0.0015
492 CYSTITIS HAEMORRHAGIC 6 0.0015
493 SEPSIS 166 0.0015
494 CHOLECYSTECTOMY 17 0.0015
495 SURGERY 87 0.0015
496 SKIN ABRASION 7 0.0015
497 INGUINAL HERNIA 9 0.0015
498 ERYTHEMA OF EYELID 8 0.0015
499 SUNBURN 11 0.0015
500 PERIPHERAL ISCHAEMIA 6 0.0015
501 ALANINE AMINOTRANSFERASE INCREASED 90 0.0015
502 FAECALOMA 8 0.0015
503 HYPERSENSITIVITY 270 0.0015
504 BLISTER 81 0.0014
505 RASH PRURITIC 78 0.0014
506 HAEMATURIA 49 0.0014
507 LUNG DISORDER 70 0.0014
508 RECTAL HAEMORRHAGE 61 0.0014
509 MUCOUS STOOLS 7 0.0014
510 RESPIRATORY DISTRESS 39 0.0014
511 ASPARTATE AMINOTRANSFERASE INCREASED 75 0.0014
512 VOMITING 663 0.0014
513 CHOLESTASIS 27 0.0014
514 HEPATIC PAIN 6 0.0014
515 PULMONARY TUBERCULOSIS 6 0.0014
516 PANCYTOPENIA 78 0.0014
517 WHITE BLOOD CELL COUNT DECREASED 151 0.0014
518 ABDOMINAL PAIN 324 0.0014
519 PNEUMOTHORAX 22 0.0014
520 MOUTH SWELLING 8 0.0014
521 VASCULITIS 16 0.0014
522 BLOOD DISORDER 11 0.0014
523 DIVERTICULUM INTESTINAL 6 0.0014
524 PRODUCT PREPARATION ISSUE 9 0.0014
525 ONYCHOMYCOSIS 6 0.0014
526 SPLENOMEGALY 16 0.0014
527 FEMORAL NECK FRACTURE 7 0.0014
528 EATING DISORDER 29 0.0014
529 MYELOSUPPRESSION 49 0.0014
530 SECRETION DISCHARGE 17 0.0014
531 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 95 0.0013
533 SEPTIC SHOCK 58 0.0013
534 POSTOPERATIVE WOUND INFECTION 9 0.0013
535 HYPOPHAGIA 34 0.0013
536 PRURITUS 511 0.0013
537 HEPATITIS CHOLESTATIC 8 0.0013
538 WOUND 37 0.0013
539 HOSPICE CARE 13 0.0013
540 HYPERKALAEMIA 46 0.0013
541 PULMONARY FIBROSIS 25 0.0013
542 DRY EYE 65 0.0013
543 LYMPHOCYTE COUNT DECREASED 23 0.0013
544 COLORECTAL CANCER STAGE IV 6 0.0013
545 INTERCEPTED PRODUCT PREPARATION ERROR 16 0.0013
546 INFLAMMATION 67 0.0013
547 INTERCEPTED MEDICATION ERROR 6 0.0013
548 INFUSION SITE EXTRAVASATION 8 0.0013
549 HYPOTHERMIA 13 0.0013
550 LYMPHOPENIA 18 0.0013
551 SKIN SWELLING 11 0.0013
552 PLEURAL EFFUSION 77 0.0013
553 VENTRICULAR FIBRILLATION 14 0.0013
554 RENAL CYST 10 0.0013
555 INFECTION 182 0.0013
556 NON-SMALL CELL LUNG CANCER 6 0.0013
557 ANGIOPATHY 7 0.0012
558 URINARY TRACT INFECTION 213 0.0012
559 DYSGEUSIA 92 0.0012
560 BACTERIAL INFECTION 23 0.0012
561 DEATH 1061 0.0012
562 ANAPHYLACTIC REACTION 68 0.0012
563 LUNG INFECTION 19 0.0012
564 BLOOD SODIUM DECREASED 23 0.0012
565 LABORATORY TEST ABNORMAL 36 0.0012
566 NEOPLASM 14 0.0012
567 EXERCISE TOLERANCE DECREASED 7 0.0012
568 LEUKOCYTOSIS 22 0.0012
569 SKIN IRRITATION 55 0.0012
570 DERMATITIS EXFOLIATIVE 6 0.0012
571 SKIN DISCOLOURATION 55 0.0012
572 HYPOVOLAEMIA 7 0.0012
573 SPINAL PAIN 14 0.0012
574 TASTE DISORDER 24 0.0012
575 BACTERAEMIA 14 0.0012
576 HAEMORRHOIDS 23 0.0012
577 BOWEL MOVEMENT IRREGULARITY 9 0.0012
578 THROMBOSIS 94 0.0012
579 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
580 CEREBRAL ISCHAEMIA 6 0.0012
581 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
582 ORAL PAIN 26 0.0012
583 HAEMOGLOBIN DECREASED 119 0.0012
584 PERITONITIS 24 0.0012
585 LOCALISED INFECTION 28 0.0012
586 EYE INFLAMMATION 11 0.0012
587 ATELECTASIS 11 0.0011
588 HYPERTENSION 241 0.0011
589 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
590 LARYNGEAL OEDEMA 7 0.0011
591 NASAL DISCOMFORT 9 0.0011
592 SINUS TACHYCARDIA 16 0.0011
593 LACRIMATION INCREASED 34 0.0011
594 ACUTE MYOCARDIAL INFARCTION 33 0.0011
595 ANGINA PECTORIS 32 0.0011
596 SWELLING OF EYELID 7 0.0011
597 EYE IRRITATION 64 0.0011
598 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
599 RENAL FAILURE ACUTE 47 0.0011
600 DECUBITUS ULCER 9 0.0011
601 ILL-DEFINED DISORDER 67 0.0011
602 PULMONARY THROMBOSIS 12 0.0011
603 HAIR DISORDER 9 0.0011
604 ACUTE RESPIRATORY FAILURE 21 0.0011
605 NAUSEA 863 0.0011
606 RETINAL DETACHMENT 10 0.0011
607 ANOREXIA 14 0.0011
608 UROSEPSIS 10 0.0011
609 SECOND PRIMARY MALIGNANCY 9 0.0011
610 PNEUMONIA ASPIRATION 27 0.0011
611 ALOPECIA 212 0.0011
612 ORAL DISCOMFORT 15 0.0011
613 HYPERTENSIVE CRISIS 12 0.0011
614 HYPERGLYCAEMIA 39 0.0011
615 DIARRHOEA HAEMORRHAGIC 10 0.0011
616 CHILLS 125 0.0011
617 CANDIDA INFECTION 18 0.0011
618 DISCOMFORT 65 0.0011
619 ACUTE KIDNEY INJURY 163 0.0011
620 HAEMATEMESIS 27 0.0011
621 HEPATIC CIRRHOSIS 20 0.0011
622 PRURITUS GENERALISED 23 0.0011
623 HYPONATRAEMIA 59 0.0010
624 ANURIA 9 0.0010
625 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
626 OXYGEN SATURATION DECREASED 58 0.0010
627 CONSTIPATION 225 0.0010
628 LIMB INJURY 28 0.0010
629 POST PROCEDURAL HAEMORRHAGE 12 0.0010
630 GASTROINTESTINAL INFLAMMATION 8 0.0010
631 LIVER INJURY 25 0.0010
632 OCULAR HYPERAEMIA 48 0.0010
633 CATARACT OPERATION 6 0.0010
634 THERAPY NON-RESPONDER 45 0.0010
635 ENDOPHTHALMITIS 6 0.0010
636 GASTRIC ULCER 19 0.0010
637 OROPHARYNGEAL DISCOMFORT 9 0.0010
638 HEPATITIS B 6 0.0010
639 RHINITIS 8 0.0010
640 HEPATOCELLULAR INJURY 14 0.0010
641 RESPIRATORY FAILURE 72 0.0010
642 BURNING SENSATION 69 0.0010
643 SHOCK HAEMORRHAGIC 8 0.0010
644 BLOOD CREATININE INCREASED 64 0.0010
645 NEPHROPATHY TOXIC 11 0.0010
646 OEDEMA 53 0.0010
647 ORAL HERPES 19 0.0010
648 DERMATITIS CONTACT 11 0.0010
649 MYOCARDITIS 11 0.0010
650 HAEMATOCRIT DECREASED 19 0.0010
651 MOUTH HAEMORRHAGE 7 0.0010
652 CYANOSIS 15 0.0010
653 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
654 RED BLOOD CELL COUNT DECREASED 27 0.0009
655 CIRCULATORY COLLAPSE 16 0.0009
656 PSYCHOLOGICAL TRAUMA 8 0.0009
657 THROMBOTIC MICROANGIOPATHY 9 0.0009
658 FATIGUE 719 0.0009
659 ADVERSE EVENT 85 0.0009
660 ATRIAL FIBRILLATION 89 0.0009
661 PROCEDURAL COMPLICATION 7 0.0009
662 TRANSAMINASES INCREASED 20 0.0009
663 WEIGHT DECREASED 250 0.0009
664 QUALITY OF LIFE DECREASED 12 0.0009
665 GASTROINTESTINAL INFECTION 8 0.0009
666 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
667 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
668 AGEUSIA 22 0.0009
669 RENAL DISORDER 41 0.0009
670 HYPOTENSION 175 0.0009
671 MULTI-ORGAN FAILURE 15 0.0009
672 ENCEPHALITIS 6 0.0009
673 VENTRICULAR EXTRASYSTOLES 9 0.0009
674 TENDERNESS 9 0.0009
675 BLOOD POTASSIUM INCREASED 14 0.0009
676 POST PROCEDURAL INFECTION 7 0.0009
677 CARDIAC FAILURE 69 0.0009
678 RENAL FAILURE 114 0.0009
679 BLOOD TEST ABNORMAL 12 0.0009
680 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
681 C-REACTIVE PROTEIN INCREASED 31 0.0009
682 EYE DISORDER 28 0.0009
683 MALAISE 373 0.0008
684 STAPHYLOCOCCAL INFECTION 28 0.0008
685 OFF LABEL USE 743 0.0008
686 COVID-19 PNEUMONIA 10 0.0008
687 DYSPHAGIA 80 0.0008
688 SWELLING FACE 54 0.0008
689 ASPIRATION 9 0.0008
690 ECZEMA 43 0.0008
691 PSEUDOMONAS INFECTION 7 0.0008
692 UVEITIS 11 0.0008
693 TACHYCARDIA 72 0.0008
694 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
695 IMMUNODEFICIENCY 12 0.0008
696 EYE INFECTION 9 0.0008
697 HAEMORRHAGE 83 0.0008
698 LUNG INFILTRATION 7 0.0008
699 RENAL IMPAIRMENT 66 0.0008
700 EPILEPSY 24 0.0008
701 HYPOGLYCAEMIA 38 0.0008
702 SYNCOPE 78 0.0008
703 URINARY RETENTION 26 0.0008
704 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
705 ANAL INCONTINENCE 7 0.0008
706 MADAROSIS 9 0.0008
707 EYELID OEDEMA 9 0.0008
708 MELAENA 17 0.0008
709 EJECTION FRACTION DECREASED 12 0.0008
710 PELVIC FRACTURE 6 0.0008
711 DYSPHONIA 45 0.0008
712 PULMONARY HAEMORRHAGE 6 0.0008
713 CARDIO-RESPIRATORY ARREST 32 0.0008
714 DEAFNESS 20 0.0008
715 PNEUMONIA BACTERIAL 7 0.0008
716 SCRATCH 8 0.0008
717 PARAESTHESIA 119 0.0008
718 CHOLECYSTITIS 9 0.0008
719 CARDIAC ARREST 62 0.0008
720 FEELING HOT 46 0.0007
721 OEDEMA PERIPHERAL 91 0.0007
722 CARDIOMYOPATHY 11 0.0007
723 RASH MACULAR 26 0.0007
724 NO THERAPEUTIC RESPONSE 9 0.0007
725 CYTOPENIA 9 0.0007
726 ESCHERICHIA INFECTION 6 0.0007
727 TOXICITY TO VARIOUS AGENTS 123 0.0007
728 THERAPY INTERRUPTED 52 0.0007
729 GENERALISED OEDEMA 9 0.0007
730 GASTROINTESTINAL DISORDER 65 0.0007
731 PANCREATITIS 38 0.0007
732 ARRHYTHMIA 34 0.0007
733 VITAMIN D DEFICIENCY 7 0.0007
734 MASS 10 0.0007
735 RENAL TUBULAR NECROSIS 7 0.0007
736 KIDNEY INFECTION 14 0.0007
737 OCULAR DISCOMFORT 8 0.0007
738 BLADDER DISORDER 7 0.0007
739 NEURALGIA 17 0.0007
740 ILLNESS 72 0.0007
741 COMA 33 0.0007
742 HYSTERECTOMY 6 0.0007
743 ENCEPHALOPATHY 17 0.0007
744 DELIRIUM 24 0.0007
745 ULCER 11 0.0007
746 PLATELET COUNT INCREASED 9 0.0007
747 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
748 LIVER FUNCTION TEST ABNORMAL 20 0.0007
749 PROCEDURAL PAIN 19 0.0007
750 GROIN PAIN 6 0.0007
751 PNEUMONIA 221 0.0007
752 PRODUCT PREPARATION ERROR 14 0.0007
753 IMMUNOSUPPRESSION 6 0.0007
754 ABDOMINAL DISTENSION 71 0.0007
755 BACK PAIN 158 0.0007
756 DRUG INTOLERANCE 65 0.0007
757 VENTRICULAR TACHYCARDIA 11 0.0007
758 DYSPNOEA 377 0.0007
759 GASTROINTESTINAL CARCINOMA 6 0.0007
760 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
761 HEMIPARESIS 11 0.0006
762 FLUSHING 66 0.0006
763 PHARYNGITIS 8 0.0006
764 URINARY INCONTINENCE 19 0.0006
765 TREATMENT FAILURE 53 0.0006
766 PANCREATITIS ACUTE 14 0.0006
767 CELLULITIS 31 0.0006
768 INTERNAL HAEMORRHAGE 7 0.0006
769 COVID-19 107 0.0006
770 GASTRIC HAEMORRHAGE 7 0.0006
771 GASTRITIS 16 0.0006
772 IMMUNE SYSTEM DISORDER 8 0.0006
773 PULMONARY OEDEMA 27 0.0006
774 HAIR TEXTURE ABNORMAL 8 0.0006
775 EYE PRURITUS 20 0.0006
776 EMPHYSEMA 6 0.0006
777 EYE SWELLING 22 0.0006
778 EYELID PTOSIS 6 0.0006
779 DISEASE RECURRENCE 28 0.0006
780 PHOTOPHOBIA 11 0.0006
781 RESPIRATORY ARREST 16 0.0006
782 DRUG EFFECT INCOMPLETE 21 0.0006
783 BURSITIS 7 0.0006
784 NERVOUS SYSTEM DISORDER 18 0.0006
785 MENTAL STATUS CHANGES 16 0.0006
786 DRUG-INDUCED LIVER INJURY 18 0.0006
787 UNEVALUABLE EVENT 43 0.0006
788 HAIR COLOUR CHANGES 7 0.0006
789 LIVER FUNCTION TEST INCREASED 12 0.0006
790 PARAESTHESIA ORAL 8 0.0006
791 THROAT TIGHTNESS 15 0.0006
792 CHOLELITHIASIS 18 0.0005
793 DRY MOUTH 44 0.0005
794 CHEST PAIN 100 0.0005
795 BODY TEMPERATURE INCREASED 11 0.0005
796 AGRANULOCYTOSIS 10 0.0005
797 NODULE 7 0.0005
798 GLOSSODYNIA 12 0.0005
799 PRESYNCOPE 13 0.0005
800 HYPOAESTHESIA 80 0.0005
801 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
802 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
803 MICTURITION URGENCY 6 0.0005
804 SHOCK 12 0.0005
805 HEPATITIS 13 0.0005
806 BLOOD PRESSURE DECREASED 33 0.0005
807 FULL BLOOD COUNT DECREASED 10 0.0005
808 HYPERCALCAEMIA 6 0.0005
809 VIRAL INFECTION 16 0.0005
810 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
811 COAGULOPATHY 8 0.0005
812 DISORIENTATION 19 0.0005
813 FRACTURE 9 0.0005
814 BLOOD URINE PRESENT 9 0.0005
815 HYPOTHYROIDISM 15 0.0005
816 SCAR 8 0.0005
817 FEELING COLD 13 0.0005
818 INFUSION SITE PAIN 6 0.0005
819 HERNIA 9 0.0005
820 NEOPLASM MALIGNANT 31 0.0005
821 HYPOAESTHESIA ORAL 7 0.0005
822 RESPIRATORY TRACT INFECTION 12 0.0005
823 HYPERHIDROSIS 59 0.0005
824 MUSCULOSKELETAL CHEST PAIN 7 0.0005
825 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
826 LIP SWELLING 15 0.0004
827 FUNGAL INFECTION 15 0.0004
828 CHROMATURIA 10 0.0004
829 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
830 URTICARIA 74 0.0004
831 PELVIC PAIN 8 0.0004
832 CYSTITIS 14 0.0004
833 HERPES ZOSTER 25 0.0004
834 DEPRESSED MOOD 23 0.0004
835 RESPIRATORY DISORDER 13 0.0004
836 ADVERSE DRUG REACTION 39 0.0004
837 BRADYCARDIA 23 0.0004
838 CARDIOVASCULAR DISORDER 11 0.0004
839 PERICARDIAL EFFUSION 10 0.0004
840 HAEMOPTYSIS 12 0.0004
841 THERAPEUTIC RESPONSE DECREASED 26 0.0004
842 ABDOMINAL PAIN UPPER 88 0.0004
843 BONE PAIN 25 0.0004
844 DEVICE OCCLUSION 6 0.0004
845 BLINDNESS UNILATERAL 6 0.0004
846 DYSARTHRIA 16 0.0004
847 MUSCULOSKELETAL DISORDER 8 0.0004
848 BLOOD UREA INCREASED 7 0.0004
849 SEIZURE 48 0.0004
850 MYELODYSPLASTIC SYNDROME 6 0.0004
851 MENTAL DISORDER 18 0.0004
852 MENTAL IMPAIRMENT 10 0.0004
853 CONDITION AGGRAVATED 124 0.0004
854 DYSURIA 15 0.0004
855 MOBILITY DECREASED 29 0.0004
856 PAIN 247 0.0004
857 SPINAL FRACTURE 8 0.0004
858 HOSPITALISATION 61 0.0004
859 HEPATIC ENZYME INCREASED 27 0.0004
860 IMPAIRED HEALING 13 0.0004
861 ABDOMINAL PAIN LOWER 10 0.0004
862 GOUT 7 0.0004
863 GAIT INABILITY 13 0.0004
864 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
865 CONVULSION 22 0.0004
866 LOSS OF CONSCIOUSNESS 49 0.0004
867 HAEMATOCHEZIA 21 0.0004
868 RETCHING 8 0.0004
869 MUSCULAR WEAKNESS 42 0.0004
870 COUGH 102 0.0004
871 SPEECH DISORDER 19 0.0004
872 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
873 VISUAL ACUITY REDUCED 12 0.0004
874 PAIN IN EXTREMITY 105 0.0004
875 CEREBROVASCULAR ACCIDENT 60 0.0004
876 CONFUSIONAL STATE 57 0.0004
877 BLOOD PRESSURE ABNORMAL 7 0.0004
878 CHEST DISCOMFORT 36 0.0004
879 INFLUENZA 39 0.0003
880 ABDOMINAL DISCOMFORT 58 0.0003
881 ORTHOSTATIC HYPOTENSION 6 0.0003
882 MUSCLE SPASMS 63 0.0003
883 SWELLING 32 0.0003
884 EYE PAIN 19 0.0003
885 CATARACT 20 0.0003
886 HEPATIC CANCER 8 0.0003
887 APHASIA 10 0.0003
888 LETHARGY 19 0.0003
889 CORONARY ARTERY DISEASE 10 0.0003
890 GAIT DISTURBANCE 63 0.0003
891 DIABETES MELLITUS 25 0.0003
892 MYOCARDIAL INFARCTION 57 0.0003
893 INSOMNIA 87 0.0003
894 FAECES DISCOLOURED 7 0.0003
895 NECK PAIN 18 0.0003
896 CARDIAC DISORDER 30 0.0003
897 SWOLLEN TONGUE 10 0.0003
898 HEART RATE DECREASED 11 0.0003
899 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
900 SNEEZING 7 0.0003
901 PERIPHERAL SWELLING 48 0.0003
902 DYSSTASIA 9 0.0003
903 DYSPEPSIA 30 0.0003
904 TINNITUS 14 0.0003
905 FREQUENT BOWEL MOVEMENTS 8 0.0003
906 DIZZINESS 147 0.0003
907 BLINDNESS 12 0.0003
908 PALLOR 8 0.0003
909 FEMUR FRACTURE 9 0.0003
910 POLLAKIURIA 12 0.0003
911 MUSCULOSKELETAL PAIN 15 0.0003
912 VISION BLURRED 39 0.0003
913 TREMOR 47 0.0003
914 HYPOACUSIS 12 0.0003
915 FLUID RETENTION 14 0.0003
916 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
917 LUNG NEOPLASM MALIGNANT 11 0.0003
918 ANXIETY 73 0.0003
919 SOMNOLENCE 51 0.0003
920 DEMENTIA 7 0.0003
921 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
922 HIP FRACTURE 8 0.0002
923 PALPITATIONS 29 0.0002
924 RESTLESSNESS 9 0.0002
925 NEPHROLITHIASIS 11 0.0002
926 RHABDOMYOLYSIS 10 0.0002
927 CONTUSION 23 0.0002
928 OROPHARYNGEAL PAIN 22 0.0002
929 RENAL INJURY 7 0.0002
930 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
931 CEREBRAL HAEMORRHAGE 8 0.0002
932 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
933 DEPRESSION 50 0.0002
934 METABOLIC ACIDOSIS 7 0.0002
935 MYALGIA 37 0.0002
936 BRONCHITIS 16 0.0002
937 ROAD TRAFFIC ACCIDENT 9 0.0002
938 COGNITIVE DISORDER 10 0.0002
939 BLOOD PRESSURE INCREASED 32 0.0002
940 ANGIOEDEMA 9 0.0002
941 WHEEZING 12 0.0002
942 DRUG INEFFECTIVE 264 0.0002
943 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
944 VERTIGO 12 0.0002
945 FALL 65 0.0002
946 OSTEOPOROSIS 8 0.0002
947 LIMB DISCOMFORT 6 0.0002
948 VISUAL IMPAIRMENT 24 0.0002
949 WEIGHT INCREASED 42 0.0002
950 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
951 RHINORRHOEA 12 0.0002
952 HEADACHE 115 0.0002
953 COLITIS ULCERATIVE 8 0.0002
954 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
955 THROAT IRRITATION 8 0.0002
956 DRUG INTERACTION 28 0.0002
957 FLATULENCE 10 0.0002
958 PRODUCT USE ISSUE 33 0.0002
959 HEART RATE INCREASED 17 0.0002
960 NASOPHARYNGITIS 31 0.0002
961 TREATMENT NONCOMPLIANCE 9 0.0002
962 VAGINAL HAEMORRHAGE 7 0.0002
963 DEVICE DISLOCATION 7 0.0002
964 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
965 DYSPNOEA EXERTIONAL 6 0.0002
966 THERAPY CESSATION 8 0.0002
967 NASAL CONGESTION 9 0.0002
968 AGITATION 11 0.0001
969 PRODUCT USE IN UNAPPROVED INDICATION 35 0.0001
970 ARTHRALGIA 56 0.0001
971 FEELING ABNORMAL 32 0.0001
972 SLEEP DISORDER 9 0.0001
973 PRODUCTIVE COUGH 6 0.0001
974 MEMORY IMPAIRMENT 17 0.0001
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
976 AMNESIA 8 0.0001
977 CHRONIC KIDNEY DISEASE 9 0.0001
978 MUSCULOSKELETAL STIFFNESS 10 0.0001
979 INJURY 8 0.0001
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
981 PROSTATE CANCER 9 0.0001
982 DRUG EFFECT DECREASED 6 0.0001
983 HOT FLUSH 8 0.0001
984 ARTHRITIS 8 0.0001
985 IRRITABILITY 6 0.0001
986 CARDIAC FAILURE CONGESTIVE 8 0.0001
987 BLOOD GLUCOSE INCREASED 18 0.0001
988 BALANCE DISORDER 8 0.0001
989 INFLUENZA LIKE ILLNESS 7 0.0001
990 EMOTIONAL DISTRESS 10 0.0001
991 PRODUCT DOSE OMISSION ISSUE 21 0.0001
992 ASTHMA 8 0.0001
993 OVERDOSE 12 0.0001
994 JOINT SWELLING 6 0.0000
995 NO ADVERSE EVENT 8 0.0000
996 INCORRECT DOSE ADMINISTERED 10 0.0000